FASLG and obesity disorder: Both obesity and hyperglycemia stimulate the release of these mediators, activating macrophages and other immune cells, as well as apoptosis-related pathways such as Fas/FasL signaling, thereby exacerbating tissue damage and muscle degradation [10].